Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 330

1.

Simultaneous approach using systemic, mucosal and transcutaneous routes of immunization for development of protective HIV-1 vaccines.

Belyakov IM, Ahlers JD.

Curr Med Chem. 2011;18(26):3953-62.

PMID:
21824096
[PubMed - indexed for MEDLINE]
2.

Generation of functionally active HIV-1 specific CD8+ CTL in intestinal mucosa following mucosal, systemic or mixed prime-boost immunization.

Belyakov IM, Ahlers JD, Nabel GJ, Moss B, Berzofsky JA.

Virology. 2008 Nov 10;381(1):106-15. doi: 10.1016/j.virol.2008.08.019. Epub 2008 Sep 14.

PMID:
18793787
[PubMed - indexed for MEDLINE]
Free Article
3.

Mucosal immunity and HIV-1 infection: applications for mucosal AIDS vaccine development.

Belyakov IM, Ahlers JD.

Curr Top Microbiol Immunol. 2012;354:157-79. doi: 10.1007/82_2010_119. Review.

PMID:
21203884
[PubMed - indexed for MEDLINE]
4.

Novel vaccination protocol with two live mucosal vectors elicits strong cell-mediated immunity in the vagina and protects against vaginal virus challenge.

Li Z, Zhang M, Zhou C, Zhao X, Iijima N, Frankel FR.

J Immunol. 2008 Feb 15;180(4):2504-13.

PMID:
18250460
[PubMed - indexed for MEDLINE]
Free Article
6.

Mucosal immunization with HIV-1 peptide vaccine induces mucosal and systemic cytotoxic T lymphocytes and protective immunity in mice against intrarectal recombinant HIV-vaccinia challenge.

Belyakov IM, Derby MA, Ahlers JD, Kelsall BL, Earl P, Moss B, Strober W, Berzofsky JA.

Proc Natl Acad Sci U S A. 1998 Feb 17;95(4):1709-14.

PMID:
9465081
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Mucosal and systemic anti-GAG immunity induced by neonatal immunization with HIV LAMP/gag DNA vaccine in mice.

Goldoni AL, Maciel M Jr, Rigato PO, Piubelli O, de Brito CA, Melo A, Marques ET, August JT, Duarte AJ, Sato MN.

Immunobiology. 2011 Apr;216(4):505-12. doi: 10.1016/j.imbio.2010.08.007. Epub 2010 Sep 25.

PMID:
20870310
[PubMed - indexed for MEDLINE]
8.

Evaluation of fowlpox-vaccinia virus prime-boost vaccine strategies for high-level mucosal and systemic immunity against HIV-1.

Ranasinghe C, Medveczky JC, Woltring D, Gao K, Thomson S, Coupar BE, Boyle DB, Ramsay AJ, Ramshaw IA.

Vaccine. 2006 Jul 26;24(31-32):5881-95. Epub 2006 May 2.

PMID:
16759767
[PubMed - indexed for MEDLINE]
9.

Functional CD8+ CTLs in mucosal sites and HIV infection: moving forward toward a mucosal AIDS vaccine.

Belyakov IM, Ahlers JD.

Trends Immunol. 2008 Nov;29(11):574-85. doi: 10.1016/j.it.2008.07.010. Review.

PMID:
18838298
[PubMed - indexed for MEDLINE]
10.

HIV-1 vaccination administered intramuscularly can induce both systemic and mucosal T cell immunity in HIV-1-uninfected individuals.

Musey L, Ding Y, Elizaga M, Ha R, Celum C, McElrath MJ.

J Immunol. 2003 Jul 15;171(2):1094-101.

PMID:
12847284
[PubMed - indexed for MEDLINE]
Free Article
11.

Studies on the generation and maintenance of mucosal cytotoxic T lymphocytes against human immunodeficiency virus type 1 Gag in mice.

Yoshizawa I, Mizuochi T, Ogata A, Murakami M, Yagita H, Takahashi Y, Mizuochi T, Takemori T, Tsunetsugu-Yokota Y.

AIDS Res Hum Retroviruses. 2003 Jun;19(6):469-79. Erratum in: AIDS Res Hum Retroviruses. 2003 Sep;19(9):836. Yagaita Hideo [corrected to Yagita Hideo].

PMID:
12882656
[PubMed - indexed for MEDLINE]
12.

Induction of gp120-specific protective immune responses by genetic vaccination with linear polyethylenimine-plasmid complex.

Garzón MR, Berraondo P, Crettaz J, Ochoa L, Vera M, Lasarte JJ, Vales A, Van Rooijen N, Ruiz J, Prieto J, Zulueta J, González-Aseguinolaza G.

Vaccine. 2005 Feb 3;23(11):1384-92.

PMID:
15661387
[PubMed - indexed for MEDLINE]
13.
14.

Prime-boost vaccination with HIV-1 Gag protein and cytosine phosphate guanosine oligodeoxynucleotide, followed by adenovirus, induces sustained and robust humoral and cellular immune responses.

Tritel M, Stoddard AM, Flynn BJ, Darrah PA, Wu CY, Wille U, Shah JA, Huang Y, Xu L, Betts MR, Nabel GJ, Seder RA.

J Immunol. 2003 Sep 1;171(5):2538-47.

PMID:
12928404
[PubMed - indexed for MEDLINE]
Free Article
15.

Gender differences in human immunodeficiency virus type 1-specific CD8 responses in the reproductive tract and colon following nasal peptide priming and modified vaccinia virus Ankara boosting.

Peacock JW, Nordone SK, Jackson SS, Liao HX, Letvin NL, Yafal AG, Gritz L, Mazzara GP, Haynes BF, Staats HF.

J Virol. 2004 Dec;78(23):13163-72.

PMID:
15542668
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Efficient systemic and mucosal responses against the HIV-1 Tat protein by prime/boost vaccination using the lipopeptide MALP-2 as adjuvant.

Borsutzky S, Ebensen T, Link C, Becker PD, Fiorelli V, Cafaro A, Ensoli B, Guzmán CA.

Vaccine. 2006 Mar 15;24(12):2049-56. Epub 2005 Nov 28.

PMID:
16406225
[PubMed - indexed for MEDLINE]
17.

Induction of strong anti-HIV cellular immunity by a combination of Clostridium perfringens expressing HIV gag and virus like particles.

Pegu P, Helmus R, Gupta P, Tarwater P, Caruso L, Shen C, Ross T, Chen Y.

Curr HIV Res. 2011 Dec 1;9(8):613-22.

PMID:
22211658
[PubMed - indexed for MEDLINE]
18.

Progress towards an AIDS mucosal vaccine: an overview.

Yuki Y, Nochi T, Kiyono H.

Tuberculosis (Edinb). 2007 Aug;87 Suppl 1:S35-44. Epub 2007 Jul 24. Review.

PMID:
17652028
[PubMed - indexed for MEDLINE]
19.

Mucosal HIV vaccines: where are we now?

Stevceva L, Strober W.

Curr HIV Res. 2004 Jan;2(1):1-10. Review.

PMID:
15053336
[PubMed - indexed for MEDLINE]
20.

Mucosal HIV-1 pox virus prime-boost immunization induces high-avidity CD8+ T cells with regime-dependent cytokine/granzyme B profiles.

Ranasinghe C, Turner SJ, McArthur C, Sutherland DB, Kim JH, Doherty PC, Ramshaw IA.

J Immunol. 2007 Feb 15;178(4):2370-9. Erratum in: J Immunol. 2007 Jun 15;178(12):8221.

PMID:
17277143
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk